frame
frame  International Workshop 2003 - Rauischholzhausen frame
frame frame frame
frame
frame frame Marburg, 28. May. 2017 frame
frame
frame Announcement
frame
frame Program
frame
frame Posters
frame
frame Location
frame
frame Accommodation
frame
frame Contact
frame
frame Application
frame
frame Technical Details
frame
frame Sponsors
frame
frame  
frame
frame AG Klebe



frame frame




Topic:

The post-genomic era has given rise to a plethora of high-throughput experimental technologies acting on a "whole-genome-basis" and aquiring new data at an unprecedented pace. What's the impact of these developments on the drug design process? How do computational drug design techniques keep pace with these developments, how well do they exploit the wealth of data, and how successful are they in turning mere "high-throughput" into better rates of valuable outcome?

Idea:

The idea of this workshop is to bring together about 90 experts in Drug Design in an informal atmosphere in order to discuss recent problems and approaches related to "post-genomic" technologies and computational drug design.

With the completion of various sequencing projects for entire organisms, the scene has - at least in principle - been set for new and accelerated approaches to drug discovery. However, to benefit from this information, technologies such as structural genomics, functional genomics, proteomics, interactomics, metabolomics, transcriptomics, pharmacogenomics etc. will be needed. Some of these have direct impact on methods in bioinformatics, involving structure prediction, homology modeling, and virtual screening. They may also help to address unsolved issues in the prediction of molecular recognition, solvation and ADMET parameters. Increasing output will also require higher efficiency in the lead finding and optimization process. Additional questions arise regarding techniques such as combinatorial chemistry and parallel synthesis: how can they profit from the information flow created by the 'omics'-methods and how efficient can the computational chemist support the compound and library design?
The workshop is planned to provide a state-of-the-art report on this multi-faceted interface between computational drug design methods and '-omics' technologies.

The workshop is organized by:


frame frame frame
frame